Literature DB >> 9089948

Virologic and immunologic events in primary HIV infection.

G Pantaleo1, C Graziosi, A S Fauci.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9089948     DOI: 10.1007/BF00813497

Source DB:  PubMed          Journal:  Springer Semin Immunopathol        ISSN: 0344-4325


× No keyword cloud information.
  47 in total

1.  Biphasic rate of CD4+ cell count decline during progression to AIDS correlates with HIV-1 phenotype.

Authors:  P T Schellekens; M Tersmette; M T Roos; R P Keet; F de Wolf; R A Coutinho; F Miedema
Journal:  AIDS       Date:  1992-07       Impact factor: 4.177

Review 2.  Immunopathogenesis of HIV infection.

Authors:  G Pantaleo; A S Fauci
Journal:  Annu Rev Microbiol       Date:  1996       Impact factor: 15.500

3.  The qualitative nature of the primary immune response to HIV infection is a prognosticator of disease progression independent of the initial level of plasma viremia.

Authors:  G Pantaleo; J F Demarest; T Schacker; M Vaccarezza; O J Cohen; M Daucher; C Graziosi; S S Schnittman; T C Quinn; G M Shaw; L Perrin; G Tambussi; A Lazzarin; R P Sekaly; H Soudeyns; L Corey; A S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  1997-01-07       Impact factor: 11.205

4.  Lymphoid organs function as major reservoirs for human immunodeficiency virus.

Authors:  G Pantaleo; C Graziosi; L Butini; P A Pizzo; S M Schnittman; D P Kotler; A S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-01       Impact factor: 11.205

Review 5.  The role of lymphoid organs in the immunopathogenesis of HIV infection.

Authors:  G Pantaleo; C Graziosi; A S Fauci
Journal:  AIDS       Date:  1993       Impact factor: 4.177

6.  Mycobacterium avium infection in HIV-1-infected subjects increases monokine secretion and is associated with enhanced viral load and diminished immune response to viral antigens.

Authors:  M Denis; E Ghadirian
Journal:  Clin Exp Immunol       Date:  1994-07       Impact factor: 4.330

7.  Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome.

Authors:  R A Koup; J T Safrit; Y Cao; C A Andrews; G McLeod; W Borkowsky; C Farthing; D D Ho
Journal:  J Virol       Date:  1994-07       Impact factor: 5.103

8.  High titers of cytopathic virus in plasma of patients with symptomatic primary HIV-1 infection.

Authors:  S J Clark; M S Saag; W D Decker; S Campbell-Hill; J L Roberson; P J Veldkamp; J C Kappes; B H Hahn; G M Shaw
Journal:  N Engl J Med       Date:  1991-04-04       Impact factor: 91.245

9.  Immunopathogenic events in acute infection of rhesus monkeys with simian immunodeficiency virus of macaques.

Authors:  K A Reimann; K Tenner-Racz; P Racz; D C Montefiori; Y Yasutomi; W Lin; B J Ransil; N L Letvin
Journal:  J Virol       Date:  1994-04       Impact factor: 5.103

10.  Cytotoxic T lymphocyte lysis inhibited by viable HIV mutants.

Authors:  U C Meier; P Klenerman; P Griffin; W James; B Köppe; B Larder; A McMichael; R Phillips
Journal:  Science       Date:  1995-11-24       Impact factor: 47.728

View more
  8 in total

1.  Weak anti-HIV CD8(+) T-cell effector activity in HIV primary infection.

Authors:  M Dalod; M Dupuis; J C Deschemin; C Goujard; C Deveau; L Meyer; N Ngo; C Rouzioux; J G Guillet; J F Delfraissy; M Sinet; A Venet
Journal:  J Clin Invest       Date:  1999-11       Impact factor: 14.808

2.  CD4 T cell recovery is slower in patients experiencing viral load rebounds during HAART.

Authors:  D Scott-Algara; J P Aboulker; C Durier; E Badell; F Marcellin; M Prud'homme; C Jouanne; V Meiffredy; F Brun-Vezinet; G Pialoux; F Raffi
Journal:  Clin Exp Immunol       Date:  2001-11       Impact factor: 4.330

3.  Large HIV-specific CD8 cytotoxic T-lymphocyte (CTL) clones reduce their overall size but maintain high frequencies of memory CTL following highly active antiretroviral therapy.

Authors:  Michael P Weekes; Mark R Wills; J G Patrick Sissons; Andrew J Carmichael
Journal:  Immunology       Date:  2006-05       Impact factor: 7.397

4.  Identifying the target cell in primary simian immunodeficiency virus (SIV) infection: highly activated memory CD4(+) T cells are rapidly eliminated in early SIV infection in vivo.

Authors:  R S Veazey; I C Tham; K G Mansfield; M DeMaria; A E Forand; D E Shvetz; L V Chalifoux; P K Sehgal; A A Lackner
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

5.  Mice chronically infected with chimeric HIV resist peripheral and brain superinfection: a model of protective immunity to HIV.

Authors:  Jennifer L Kelschenbach; Manisha Saini; Eran Hadas; Chao-Jiang Gu; Wei Chao; Galina Bentsman; Jessie P Hong; Tomas Hanke; Leroy R Sharer; Mary Jane Potash; David J Volsky
Journal:  J Neuroimmune Pharmacol       Date:  2011-10-11       Impact factor: 4.147

6.  Human immunodeficiency virus type 1 gag-specific mucosal immunity after oral immunization with papillomavirus pseudoviruses encoding gag.

Authors:  Hongtao Zhang; Raja Fayad; Xilin Wang; Daniel Quinn; Liang Qiao
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

7.  HIV-1 induced activation of CD4+ T cells creates new targets for HIV-1 infection in human lymphoid tissue ex vivo.

Authors:  Angélique Biancotto; Sarah J Iglehart; Christophe Vanpouille; Cristian E Condack; Andrea Lisco; Elke Ruecker; Ivan Hirsch; Leonid B Margolis; Jean-Charles Grivel
Journal:  Blood       Date:  2007-10-01       Impact factor: 22.113

8.  Altered distribution of mucosal NK cells during HIV infection.

Authors:  M Sips; G Sciaranghella; T Diefenbach; A-S Dugast; C T Berger; Q Liu; D Kwon; M Ghebremichael; J D Estes; M Carrington; J N Martin; S G Deeks; P W Hunt; G Alter
Journal:  Mucosal Immunol       Date:  2011-10-12       Impact factor: 7.313

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.